Wanner, C., Heerspink, H., Zinman, B., Inzucchi, S., Koitka-Weber, A., Mattheus, M., . . . Malano, J. (2018). Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial. AMER SOC NEPHROLOGY.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
Wanner, C., et al. Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial. AMER SOC NEPHROLOGY, 2018.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
Wanner, C., et al. Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial. AMER SOC NEPHROLOGY, 2018.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.